Oncology Institute (DFPH) Non-Current Debt (2020 - 2025)
Historic Non-Current Debt for Oncology Institute (DFPH) over the last 5 years, with Q3 2025 value amounting to $76.2 million.
- Oncology Institute's Non-Current Debt fell 1676.04% to $76.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year decrease of 1676.04%. This contributed to the annual value of $93.1 million for FY2024, which is 726.16% up from last year.
- Oncology Institute's Non-Current Debt amounted to $76.2 million in Q3 2025, which was down 1676.04% from $75.0 million recorded in Q2 2025.
- Oncology Institute's 5-year Non-Current Debt high stood at $93.1 million for Q4 2024, and its period low was $73.9 million during Q1 2025.
- In the last 4 years, Oncology Institute's Non-Current Debt had a median value of $83.7 million in 2023 and averaged $83.5 million.
- As far as peak fluctuations go, Oncology Institute's Non-Current Debt soared by 782.23% in 2023, and later plummeted by 1676.04% in 2025.
- Quarter analysis of 4 years shows Oncology Institute's Non-Current Debt stood at $80.6 million in 2022, then rose by 7.7% to $86.8 million in 2023, then increased by 7.26% to $93.1 million in 2024, then decreased by 18.19% to $76.2 million in 2025.
- Its last three reported values are $76.2 million in Q3 2025, $75.0 million for Q2 2025, and $73.9 million during Q1 2025.